Model-based assessment of alternative study designs in pediatric trials. Part I: Frequentist approaches

G. Smania, P. Baiardi, A. Ceci, P. Magni, M. Cella

Research output: Contribution to journalArticlepeer-review

Abstract

Alternative designs can increase the feasibility of pediatric trials when compared to classical parallel designs (PaD). In this work we present a model-based approach based on clinical trial simulations for the comparison of PaD with the alternative sequential, crossover, and randomized withdrawal (RWD) designs. Study designs were evaluated in terms of: type I and II errors, sample size per arm (SS), trial duration (TD), treatment exposures, and parameter estimate precision (EP). The crossover requires the lowest SS and TD, although it implies higher placebo and no treatment exposures. RWD maximizes exposure to active treatment while minimizing that to placebo, but requires the largest SS. SS of sequential designs can sometimes be smaller than the crossover one, although with poorer EP. This pharmacometric framework allows a multiscale comparison of alternative study designs that can be used for design selection in future pediatric trials.

Original languageEnglish
Pages (from-to)305-312
Number of pages8
JournalCPT: Pharmacometrics and Systems Pharmacology
Volume5
Issue number6
DOIs
Publication statusPublished - Jun 1 2016

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Model-based assessment of alternative study designs in pediatric trials. Part I: Frequentist approaches'. Together they form a unique fingerprint.

Cite this